Together we can heal the world.

The world needs

to feel better.

Who we are.

The Huxley Group is a global biotechnology enterprise focused on the development and commercialization of psychedelic inspired therapeutics, and mushroom-based natural health products.

Science compels us to build this company

1 in 2

North Americans have had a mental illness by age 40

100%

Increase in depression among North Americans since beginning of the COVID-19 pandemic

25%

Global increase in depression and anxiety since beginning of the COVID-19 pandemic

THE COST

As a global problem,
mental illness is costing us all.

1 in 5 North Americas are affected by mental illness, for a total of $321 Billions per year.

1 in 7

People in the world experience mental illness

$16 Trillion

Is the estimated economic burden (in USD) per year

Someone in the world

commits suicide every
40 seconds.

Current treatment protocols are not working

They produce poor outcomes and come at a high cost.

Current Pharmacotherapies are inadequate.

Up to 50% of patients do not respond fully to treatment. 10 to 30% of them are treatment-resistant.

Access to psychotherapy is limited.

There’s a shortage of mental health professionals and long waiting lists. Much of this therapy comes with high out-of-pocket payments for patients.

Response and compliance are poor.

or patients in need are not receiving treatment at all. There’s a high-risk for substance abuse and suicidal tendencies.

Our Mission

We passionately believe the precision science can heal the world by harnessing nature's own toolbox.

To heal

the world in mind, body, and spirit.

To create value

and make a difference in the world.

To be recognized

for discoveries in the field of mental health and well-being.